Dihydropyrimidine dehydrogenase activity in cancer patients
Authors:
- G.A. MilanoGMG.A. Milano
- M.H. GaspardMGM.H. Gaspard
- A. ThyssATA. Thyss
- N. RenéeNRN. Renée
- M. SchneiderMSM. Schneider
- F. DemardFDF. Demard
- P.J. BargnouxPBP.J. Bargnoux
- R. PlagneRPR. Plagne
- 1 January 1993
- journal article
- case report
- Published by Elsevier in European Journal of Cancer
- Vol. 29 (5) , 740-744
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of age and gender on in vitro properties of human liver microsomal monooxygenasesClinical Pharmacology & Therapeutics, 1990
- A new case of dihydropyrimidine dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1989
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastasesBritish Journal of Cancer, 1988
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988
- Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil ToxicityNew England Journal of Medicine, 1985
- Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolismClinica Chimica Acta, 1984
- Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiencyClinica Chimica Acta, 1984
- A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximationJournal of Pharmacokinetics and Biopharmaceutics, 1978
- The reduction of thymine by human leukocytesArchives of Biochemistry and Biophysics, 1964